1 We used data from 13 European and North American cohorts of h
2 We used data from 21 villages of the Agincourt Health and soc
3 We used data from 3 large databases of patients from studies
4 nd overall and according to sex, age, education, and income.
We used data from 4 national Swiss Health Surveys conducted b
5 We used data from 420 patients with hepatocellular carcinoma
6 We used data from 5 one-month registries, conducted 5 years a
7 Patients and Methods
We used data from 796,594 population-based English General Pr
8 We used data from a 4-y longitudinal caries-risk assessment s
9 We used data from a large cohort study (the 2001 Canadian Cen
10 We used data from a nationwide cross-sectional survey (the Ch
11 ployed military personnel with and without combat exposure,
we used data from a population-based representative sample of
12 In this mendelian randomisation study,
we used data from cohort studies, randomised controlled trial
13 For clinical quality,
we used data from direct observations of care to calculate pr
14 our previous laboratory-based prediction model (Globorisk),
we used data from eight prospective studies to estimate coeff
15 In this retrospective analysis,
we used data from eight randomised clinical trials with metas
16 We used data from GBD 2015 for 315 causes and 79 risk factors
17 We used data from GBD 2015 with the aim to quantify the burde
18 In this systematic assessment,
we used data from national census reports, National Statistic
19 We used data from nine testing occasions spanning 28 y in the
20 In this international cohort study,
we used data from propensity-matched patients with relapsing-
21 In this observational study,
we used data from prospective studies of HIV-positive individ
22 We used data from published studies of chlamydia-infected men
23 We used data from six cohorts of participants aged 50 years o
24 We used data from the 1997 to 2009 National Health Interview
25 We used data from the 1999-2010 U.S. National Health and Nutr
26 To develop and validate these risk equations,
we used data from the Action to Control Cardiovascular Risk i
27 ed to excess glucose consumption by the preclinical tumour,
we used data from the Apolipoprotein MOrtality RISk (AMORIS)
28 In this study,
we used data from the baseline census conducted as part of th
29 We used data from the Breastfeeding, Antiretrovirals and Nutr
30 We used data from the Chinese Longitudinal Healthy Longevity
31 We used data from the English and Romanian Adoptees study to
32 We used data from the Get With The Guidelines-Stroke program
33 We used data from the Gulf Long-term Follow-up Study, a cohor
34 We used data from the male segment of a 25-year study of the
35 We used data from the National Cancer Database, a hospital-ba
36 Next,
we used data from the National Climatic Data Center to estima
37 gastric cancers and their different subtypes.In this study
we used data from the NIH-AARP Diet and Health Study, which e
38 We used data from the Obesity Research Study for Mexican chil
39 We used data from the Organ Procurement and Transplantation N
40 We used data from the Rugao Longevity and Ageing Study, a pop
41 We used data from the Scottish diabetes register that were li
42 We used data from the Shanghai Men's Health Study (2002-2013)
43 related mortality, and tuberculosis notification rates, and
we used data from the South African National AIDS Council to
44 We used data from the U.S. Census Bureau on population projec
45 In this longtitudinal analysis,
we used data from the UK Millennium Cohort Study, a large nat
46 We used data from the year 2012 (January 1 through December 3
47 We used data from transmission experiments in cattle where bo
48 Here
we used data from two independent functional magnetic resonan
49 We used data from two representative household surveys, one d
50 We used data from up to 2405 participants from the Spanish In